CN115598231B - 定量包含非离子表面活性剂和多肽的组合物中非离子表面活性剂的层析方法 - Google Patents

定量包含非离子表面活性剂和多肽的组合物中非离子表面活性剂的层析方法

Info

Publication number
CN115598231B
CN115598231B CN202210633310.1A CN202210633310A CN115598231B CN 115598231 B CN115598231 B CN 115598231B CN 202210633310 A CN202210633310 A CN 202210633310A CN 115598231 B CN115598231 B CN 115598231B
Authority
CN
China
Prior art keywords
mobile phase
composition
antibody
polypeptide
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210633310.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN115598231A (zh
Inventor
M·蒙蒂
R·L·比尔兹利
M·S·钦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN115598231A publication Critical patent/CN115598231A/zh
Application granted granted Critical
Publication of CN115598231B publication Critical patent/CN115598231B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/96—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation using ion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3847—Multimodal interactions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/26—Conditioning of the fluid carrier; Flow patterns
    • G01N30/28—Control of physical parameters of the fluid carrier
    • G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/26—Conditioning of the fluid carrier; Flow patterns
    • G01N30/28—Control of physical parameters of the fluid carrier
    • G01N30/36—Control of physical parameters of the fluid carrier in high pressure liquid systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
CN202210633310.1A 2016-08-15 2017-08-14 定量包含非离子表面活性剂和多肽的组合物中非离子表面活性剂的层析方法 Active CN115598231B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662375373P 2016-08-15 2016-08-15
US62/375,373 2016-08-15
CN201780057815.5A CN109716127B (zh) 2016-08-15 2017-08-14 定量包含非离子表面活性剂和多肽的组合物中非离子表面活性剂的层析方法
PCT/US2017/046725 WO2018035025A1 (en) 2016-08-15 2017-08-14 Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201780057815.5A Division CN109716127B (zh) 2016-08-15 2017-08-14 定量包含非离子表面活性剂和多肽的组合物中非离子表面活性剂的层析方法

Publications (2)

Publication Number Publication Date
CN115598231A CN115598231A (zh) 2023-01-13
CN115598231B true CN115598231B (zh) 2025-11-18

Family

ID=59687053

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202210633310.1A Active CN115598231B (zh) 2016-08-15 2017-08-14 定量包含非离子表面活性剂和多肽的组合物中非离子表面活性剂的层析方法
CN201780057815.5A Active CN109716127B (zh) 2016-08-15 2017-08-14 定量包含非离子表面活性剂和多肽的组合物中非离子表面活性剂的层析方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201780057815.5A Active CN109716127B (zh) 2016-08-15 2017-08-14 定量包含非离子表面活性剂和多肽的组合物中非离子表面活性剂的层析方法

Country Status (17)

Country Link
US (2) US11333644B2 (https=)
EP (1) EP3497440B1 (https=)
JP (1) JP7286536B2 (https=)
KR (1) KR102617148B1 (https=)
CN (2) CN115598231B (https=)
AR (1) AR109343A1 (https=)
AU (2) AU2017312540B2 (https=)
BR (1) BR112019002979B1 (https=)
ES (1) ES3034020T3 (https=)
HR (1) HRP20250718T1 (https=)
HU (1) HUE071741T2 (https=)
IL (1) IL264582B (https=)
MX (2) MX2019001572A (https=)
PL (1) PL3497440T3 (https=)
SG (1) SG11201901228QA (https=)
TW (1) TWI775770B (https=)
WO (1) WO2018035025A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210139387A1 (en) * 2016-01-19 2021-05-13 Genebiologics, Llc Production of Arginine-Rich Proteins from Wastewater and Use as a Fertilizer
HRP20250718T1 (hr) 2016-08-15 2025-08-15 F. Hoffmann-La Roche Ag Kromatografski postupak za kvantifikaciju neionskog surfaktanta u sastavu koji sadrži neionski surfaktant i polipeptid
TWI870390B (zh) * 2019-02-27 2025-01-21 法商賽諾菲公司 以具內標之lc-ms於樣品中進行聚山梨醇酯定量之方法
CN113424057B (zh) * 2019-04-19 2024-04-05 海正生物制药有限公司 组合物中泊洛沙姆188的检测方法
JP2022531317A (ja) 2019-05-03 2022-07-06 ジェネンテック， インコーポレイテッド 精製プラットフォームから得られた組成物中の酵素加水分解活性速度を低下させる方法
EP4090666A1 (en) 2020-01-15 2022-11-23 F. Hoffmann-La Roche AG Methods to decrease impurities from recombinant protein manufacturing processes
CA3198684A1 (en) 2020-10-30 2022-05-05 Genentech, Inc. Purification platforms for obtaining pharmaceutical compositions having a reduced hydrolytic enzyme activity rate
BR112023016996A2 (pt) 2021-02-24 2023-09-26 Hoffmann La Roche Métodos para purificar um polipeptídeo terapêutico e para produzir um polipeptídeo terapêutico e usos de uma solução ácida e de uma solução alcalina
KR102283871B1 (ko) * 2021-03-02 2021-08-02 한국원자력연구원 크로마토그래피를 이용한 무담체 홀뮴-166의 분리 방법, 분리 장치 및 이에 의하여 분리된 무담체 홀뮴-166
AU2022429920A1 (en) * 2021-12-31 2024-07-25 Kashiv Biosciences, Llc A process for separation and quantification of non-ionic surfactant
WO2024145244A1 (en) * 2022-12-30 2024-07-04 Eli Lilly And Company Methods for measuring levels of polysorbate(s)
WO2026062617A1 (en) * 2024-09-23 2026-03-26 Janssen Pharmaceuticals, Inc. Methods for detection and quantification of surfactants

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS61141719A (ja) * 1984-08-22 1986-06-28 キュノ、インコ−ポレ−テッド 変性ポリペプチド支持体
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
DE3850542T2 (de) 1987-09-23 1994-11-24 Bristol Myers Squibb Co Antikörper-Heterokonjugate zur Töting von HIV-infizierten Zellen.
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
ES2096590T3 (es) 1989-06-29 1997-03-16 Medarex Inc Reactivos biespecificos para la terapia del sida.
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
WO1992020373A1 (en) 1991-05-14 1992-11-26 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
EP1400536A1 (en) 1991-06-14 2004-03-24 Genentech Inc. Method for making humanized antibodies
MX9204374A (es) 1991-07-25 1993-03-01 Idec Pharma Corp Anticuerpo recombinante y metodo para su produccion.
US7018809B1 (en) 1991-09-19 2006-03-28 Genentech, Inc. Expression of functional antibody fragments
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
FI941572A7 (fi) 1991-10-07 1994-05-27 Oncologix Inc Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenete lmä
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
ATE207080T1 (de) 1991-11-25 2001-11-15 Enzon Inc Multivalente antigen-bindende proteine
CA2372813A1 (en) 1992-02-06 1993-08-19 L.L. Houston Biosynthetic binding protein for cancer marker
WO1993016177A1 (en) 1992-02-11 1993-08-19 Cell Genesys, Inc. Homogenotization of gene-targeting events
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
CA2140280A1 (en) 1992-08-17 1994-03-03 Avi J. Ashkenazi Bispecific immunoadhesins
DK0752248T3 (da) 1992-11-13 2000-11-13 Idec Pharma Corp Terapeutisk anvendelse af kimæriske og radioaktivt mærkede antistoffer mod humant B-lymfocytbegrænset differentieringsantig
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5712374A (en) 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
JPH0943218A (ja) * 1995-08-04 1997-02-14 Kao Corp 非イオン界面活性剤の分析方法
WO1999050655A1 (en) * 1998-03-30 1999-10-07 Cell Therapeutics, Inc. Methods of separation and detection
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
US8372954B2 (en) 2000-12-22 2013-02-12 National Research Council Of Canada Phage display libraries of human VH fragments
JP2005289809A (ja) 2001-10-24 2005-10-20 Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) 突然変異重鎖抗体
GB0310347D0 (en) * 2003-05-07 2003-06-11 Delta Biotechnology Ltd Assay
DE602004017726D1 (de) 2003-06-30 2008-12-24 Domantis Ltd Pegylierte Single-domain-antikörper (dAb)
AU2005285347A1 (en) 2004-08-19 2006-03-23 Genentech, Inc. Polypeptide variants with altered effector function
DK1791565T3 (en) 2004-09-23 2016-08-01 Genentech Inc Cysteingensplejsede antibodies and conjugates
EP1833877A2 (en) * 2004-12-21 2007-09-19 Baxter International Inc. (polyalkoxy)sulfonate surface modifiers
US7241586B2 (en) * 2005-02-17 2007-07-10 Medtronic Minimed, Inc. Polypeptide formulations and methods for making, using and characterizing them
WO2010141426A1 (en) 2009-06-01 2010-12-09 Waters Technologies Corporation Hybrid material for chromatographic separations
US20120294866A1 (en) * 2010-01-19 2012-11-22 F. Hoffmann-La Roche Ag Pharmaceutical formulation for proteins
KR101976853B1 (ko) 2010-05-25 2019-05-09 제넨테크, 인크. 폴리펩티드의 정제 방법
JP5193266B2 (ja) 2010-11-16 2013-05-08 株式会社ミノファーゲン製薬 生薬由来成分の高感度定量方法
SG10201606218WA (en) * 2011-07-29 2016-09-29 Eleven Biotherapeutics Inc Purified Proteins
HUE035685T2 (en) * 2011-11-02 2018-05-28 Hoffmann La Roche Overload and elute chromatography
JP6129302B2 (ja) * 2012-05-23 2017-05-17 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 混合物中のポリソルベート種の濃度を決定するための方法
HRP20250718T1 (hr) 2016-08-15 2025-08-15 F. Hoffmann-La Roche Ag Kromatografski postupak za kvantifikaciju neionskog surfaktanta u sastavu koji sadrži neionski surfaktant i polipeptid

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Quantitation of polysorbate 20 in protein solutions using mixed-mode chromatography and evaporative light scattering detection;Daniel Hewitt et al.;Journal of Chromatography A;20081214;第1215卷;摘要、第1节、第2.2-2.3节、第3.1节、表1、图2 *
使用Oasis在线SPE柱进行LC/MS/MS分析;Waters;维护和使用手册;20080731;第2页第1栏第1段、第3页第1栏第1段 *

Also Published As

Publication number Publication date
AU2017312540A1 (en) 2019-02-28
HUE071741T2 (hu) 2025-09-28
EP3497440A1 (en) 2019-06-19
JP2019530857A (ja) 2019-10-24
HRP20250718T1 (hr) 2025-08-15
MX2024006922A (es) 2024-06-20
PL3497440T3 (pl) 2025-08-04
IL264582A (en) 2019-02-28
KR20190051977A (ko) 2019-05-15
EP3497440B1 (en) 2025-04-30
TWI775770B (zh) 2022-09-01
BR112019002979B1 (pt) 2023-10-03
AR109343A1 (es) 2018-11-21
MX2019001572A (es) 2019-08-29
IL264582B (en) 2022-04-01
KR102617148B1 (ko) 2023-12-26
AU2022291517B2 (en) 2024-12-12
SG11201901228QA (en) 2019-03-28
AU2017312540B2 (en) 2023-02-02
ES3034020T3 (en) 2025-08-12
US20190178859A1 (en) 2019-06-13
CN115598231A (zh) 2023-01-13
BR112019002979A2 (pt) 2019-07-09
AU2022291517A1 (en) 2023-02-02
JP7286536B2 (ja) 2023-06-05
EP3497440C0 (en) 2025-04-30
US11680931B2 (en) 2023-06-20
US11333644B2 (en) 2022-05-17
WO2018035025A1 (en) 2018-02-22
TW201809658A (zh) 2018-03-16
CN109716127A (zh) 2019-05-03
CN109716127B (zh) 2022-06-14
US20230077255A1 (en) 2023-03-09
CA3033737A1 (en) 2018-02-22

Similar Documents

Publication Publication Date Title
CN115598231B (zh) 定量包含非离子表面活性剂和多肽的组合物中非离子表面活性剂的层析方法
US10712322B2 (en) Ionic strength-mediated pH gradient ion exchange chromatography
JP6462681B2 (ja) イオン交換クロマトグラフィーのインプットの最適化の解明
CA3033737C (en) Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide
HK40087648B (zh) 定量包含非离子表面活性剂和多肽的组合物中非离子表面活性剂的层析方法
HK40087648A (zh) 定量包含非离子表面活性剂和多肽的组合物中非离子表面活性剂的层析方法
HK40007967A (en) Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide
HK40007967B (en) Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40087648

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant